Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

Background/Aims: Clarithromycin resistance is a main factor for treatment failure in the context of Helicobacter pylori infection. However, the treatment regimen for clarithromycin-resistant H. pylori infection has not yet been determined. We aimed to compare the efficacy and cost-effectiveness of 1...

Full description

Bibliographic Details
Main Authors: Seung In Seo, Hyun Lim, Chang Seok Bang, Young Joo Yang, Gwang Ho Baik, Sang Pyo Lee, Hyun Joo Jang, Sea Hyub Kae, Jinseob Kim, Hak Yang Kim, Woon Geon Shin
Format: Article
Language:English
Published: Gastroenterology Council for Gut and Liver 2022-09-01
Series:Gut and Liver
Subjects:
helicobacter pylori
clarithromycin
drug resistance
point mutation
therapy
Online Access:http://gutnliver.org/journal/view.html?doi=10.5009/gnl210365

Internet

http://gutnliver.org/journal/view.html?doi=10.5009/gnl210365

Similar Items